Cited 0 times in
Real-world treatment outcomes of amivantamab in pre-approval access (PAA) participants with advanced non-small cell lung cancer (NSCLC) with EGFR exon 20 insertion mutations (ex20ins)
DC Field | Value | Language |
---|---|---|
dc.date.accessioned | 2023-06-02T01:09:51Z | - |
dc.date.available | 2023-06-02T01:09:51Z | - |
dc.date.issued | 2022-04 | - |
dc.identifier.issn | 0923-7534 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/194699 | - |
dc.description.statementOfResponsibility | restriction | - |
dc.language | English | - |
dc.publisher | Oxford University Press | - |
dc.relation.isPartOf | ANNALS OF ONCOLOGY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.title | Real-world treatment outcomes of amivantamab in pre-approval access (PAA) participants with advanced non-small cell lung cancer (NSCLC) with EGFR exon 20 insertion mutations (ex20ins) | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
dc.contributor.googleauthor | T.M. Kim | - |
dc.contributor.googleauthor | S-H. Lee | - |
dc.contributor.googleauthor | G-C. Chang | - |
dc.contributor.googleauthor | J-Y. Shih | - |
dc.contributor.googleauthor | M.J. Hochmair | - |
dc.contributor.googleauthor | J.K. Sabari | - |
dc.contributor.googleauthor | A.I. Spira | - |
dc.contributor.googleauthor | C.A. Schioppa | - |
dc.contributor.googleauthor | J.B. Rose | - |
dc.contributor.googleauthor | M. Chioda | - |
dc.contributor.googleauthor | A. Panaccione | - |
dc.contributor.googleauthor | P. Mahadevia | - |
dc.contributor.googleauthor | B.C. Cho | - |
dc.identifier.doi | 10.1016/j.annonc.2022.02.044 | - |
dc.relation.journalcode | J00171 | - |
dc.identifier.eissn | 1569-8041 | - |
dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S0923753422001600 | - |
dc.citation.volume | 33 | - |
dc.citation.number | suppl 2 | - |
dc.citation.startPage | S48 | - |
dc.identifier.bibliographicCitation | ANNALS OF ONCOLOGY, Vol.33(suppl 2) : S48, 2022-04 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.